In today’s recent session, 5.86 million shares of the Salarius Pharmaceuticals Inc (NASDAQ:SLRX) have been traded, and its beta is 0.51. Most recently the company’s share price was $0.87, and it changed around -$0.08 or -8.05% from the last close, which brings the market valuation of the company to $1.53M. SLRX at last check was trading at a discount to its 52-week high of $7.20, offering almost -727.59% off that amount. The share price’s 52-week low was $0.83, which indicates that the recent value has risen by an impressive 4.6% since then. We note from Salarius Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 57800.0 shares, with the 3-month average coming to 2.21 million.

Salarius Pharmaceuticals Inc (NASDAQ:SLRX) trade information

Instantly SLRX has been showing red trend so far today with a performance of -8.05% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.0200 on recent trading dayincreased the stock’s daily price by 14.71%. The company’s shares are currently down -52.53% year-to-date, but still up 1.39% over the last five days. On the other hand, Salarius Pharmaceuticals Inc (NASDAQ:SLRX) is -22.01% down in the 30-day period. We can see from the shorts that 85721.0 shares have been sold at a short interest cover period of 0.47 day(s).

Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 2.10% of Salarius Pharmaceuticals Inc shares, and 4.80% of them are in the hands of institutional investors. The stock currently has a share float of 4.90%.

Fidelity Extended Market Index Fund and Horizon Kinetics Medical ETF were the top two Mutual Funds as of Dec 31, 2024. The former held 5.74 shares worth $4914.0, making up 0.33% of all outstanding shares. On the other hand, Horizon Kinetics Medical ETF held roughly 3.89 shares worth around $3328.0, which represents about 0.22% of the total shares outstanding.